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Production of hybrid chimeric PVX 
Particles Using a combination of 
TMV and PVX-Based expression 
Vectors
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We have generated hybrid chimeric potato virus X (PVX) particles by coexpression of 
different PVX coat protein fusions utilizing tobacco mosaic virus (TMV) and PVX-based 
expression vectors. Coinfection was achieved with a modified PVX overcoat vector 
displaying a fluorescent protein and a TMV vector expressing another PVX fluorescent 
overcoat fusion protein. Coexpression of the PVX-CP fusions in the same cells was 
confirmed by epifluorescence microscopy. Labeling with specific antibodies and trans-
mission electron microscopy revealed chimeric particles displaying green fluorescent 
protein and mCherry on the surface. These data were corroborated by bimolecular 
fluorescence complementation. We used split-mCherry fragments as PVX coat fusions 
and confirmed an interaction between the split-mCherry fragments in coinfected cells. 
The presence of assembled split-mCherry on the surface confirmed the hybrid character 
of the chimeric particles.
Keywords: potato virus X, tobacco mosaic virus, hybrid chimeric particles, viral vectors, coexpression, fluorescent 
proteins, nanoparticles
inTrODUcTiOn
Plant virus particles offer an excellent tool for pharmaceutical and nanotechnological applications. 
They can consist of multiple identical copies of one or two coat protein (CP) subunits and can be eas-
ily modified by genetic engineering or chemical conjugation (Meunier et al., 2004; Chatterji et al., 
2005; Steinmetz, 2010; Rego et al., 2013; Lee et al., 2014). Plant virus capsids offer suitable building 
blocks for areas of research and application as diverse as electronic devices, composite materials, 
and vaccine production. There is a growing demand for inexpensive vaccines that can be distributed 
and stored without maintaining the cold chain, particularly in developing countries which lack 
an appropriate infrastructure (Ma et al., 2005b). This exacerbates even simple infectious diseases 
and ultimately leads to a high child mortality rate (Hefferon, 2013). Although plant virus particles 
Abbreviations: BiFC, bimolecular fluorescence complementation; C-mC, C-terminal part of split-mCherry; CP, coat protein; 
FDMV, foot and mouth disease virus; GFP, green fluorescent protein; HCV, hepatitis virus C; ISEM, immunosorbent transmis-
sion electron microscopy; mRFP, monomeric red fluorescent protein; N-mC, N-terminal part of split-mCherry; NMD, non-
sense-mediated decay.; ORF, open reading frame; PBS, phosphate-buffered saline; PVX, potato virus X; RdRp, RNA-dependent 
RNA polymerase; TEM, transmission electron microscopy; TGB, triple gene block; TMV, tobacco mosaic virus.
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might also need cold storage after purification, the lifetime and 
stability in plant material is better compared to other vaccine 
production systems.
Plants are considered a promising alternative production sys-
tem for pharmaceuticals and have been studied extensively over 
the past decades (Fischer et  al., 2012; Lico et  al., 2012; Melnik 
and Stoger, 2013). Plant virus particles or CPs are ideal for the 
presentation of epitopes (Porta and Lomonossoff, 1998; Yusibov 
et al., 2006; Morgenfeld et al., 2009; Rosenthal et al., 2014). They 
can be produced in large amounts in plants as bioreactors, with 
inexpensive growth conditions and a minimal risk of contami-
nation with animal pathogens (Twyman et  al., 2003; Ma et  al., 
2005a). Plant virus particles and CPs as carrier molecules enhance 
the immunogenicity of peptides by presenting them robustly to 
the immune system (Lomonossoff and Evans, 2014). When the 
target epitope is inserted at an appropriate site on the selected 
plant viral CP, they can assemble to intact particles displaying 
the foreign peptide on the outer surface (Johnson et al., 1997). 
Immune responses against single pathogen epitopes are in most 
cases not sufficient to provide protection against an infection. 
Often different genotypes or subtypes of pathogens are found, 
e.g., the mammalian virus Hepatitis C virus (HCV) (Simmonds 
et al., 2005). This makes a vaccine development difficult, which 
is further complicated by the degree of heterogeneity in infected 
individuals due to the pathogen mutation rate (Hayashi et  al., 
1999). The presentation of several different epitopes from the 
same pathogen or from several different pathogens is ideal for 
the construction of efficient vaccines (Sette et al., 2001; Awram 
et al., 2002).
Several plant viruses have been developed as epitope presen-
tation systems. The most widely used are cowpea mosaic virus 
(CPMV) (Brennan et al., 2001; Gonzalez et al., 2009; Sainsbury 
et  al., 2010) and tobacco mosaic virus (TMV) (Sugiyama et  al., 
1995; Porta and Lomonossoff, 1998). Another promising plant 
virus for epitope presentation is potato virus X (PVX), the type 
member of the genus Potexvirus in the virus family Flexiviridae 
(Adams et al., 2004). Solanaceae (e.g., potato, tomato, and tobacco) 
are infected by PVX and the virus is transmitted mechanically 
from plant to plant (Koenig, 1971). PVX has a +ssRNA genome 
6.4 kb in length, with a 5'-methylguanosine cap, a polyadenylated 
3' tail, and five ORFs (Koonin, 1991; Kim and Hemenway, 1997). 
The RNA-dependent RNA polymerase (RdRp) is the first ORF 
and is the only virus protein needed for viral RNA synthesis and 
replication (Draghici et al., 2009). The next three ORFs overlap, 
and encode the p25, p12, and p8 triple gene block (TGB) pro-
teins necessary for the cell-to-cell transport (Beck et  al., 1991; 
Angell and Baulcombe, 1997; Verchot et al., 1998). The last ORF 
at the 3' end encodes the CP. Approximately 1270 CP subunits 
assemble with the plus-strand RNA into the viral particle (Tollin 
and Wilson, 1988). Furthermore, the CP is also important for 
cell-to-cell movement and long distance transport through the 
plant (Chapman et al., 1992; Baulcombe et al., 1995; Cruz et al., 
1998). The virus particles have a size of 515 nm × 13.5 nm and 
are flexuous rods (Tollin and Wilson, 1988; Atabekov et al., 2007). 
Flexuous particles have, in general, the advantage of no intrinsic 
size limitations or packaging constraints and potentially many 
copies of the target peptide can be presented on the surface (Uhde 
et al., 2005). The N-terminal portion of the PVX CP is exposed 
on the virion surface (Koenig and Torrance, 1986; Baratova et al., 
1992), making N-terminal fusions to the CP the ideal strategy 
for epitope presentation. Several epitopes had been presented as 
PVX CP fusions, including the 2F5 epitope of the human immu-
nodeficiency virus (HIV) (Marusic et al., 2001), an epitope of the 
Influenza A virus nucleoprotein (Lico et  al., 2009), and the R9 
peptide of HCV (Uhde-Holzem et al., 2010). In all these cases, 
robust immune responses were achieved in animal models.
Limiting factors for peptide fusions to the PVX CP is the size 
and the isoelectric point (pI) of the target epitope. The inserted 
sequences can impair virus assembly and systemic infection 
(Uhde-Holzem et  al., 2007). Thus far, the maximum epitope 
sequence that has been displayed as a direct CP fusion on the par-
ticle surface was 14 residues in length (Uhde-Holzem et al., 2010). 
For the display of larger sequences, the 2A sequence from foot 
and mouth disease virus (FMDV) is inserted between the peptide 
and the CP. The 2A sequence confers a cotranslational ribosomal 
skip, leading to a production of non-fused CP and CP fusion 
product in a certain ratio depending on the amino acid sequence 
(Donnelly et al., 2001a,b). In this way, complete proteins can be 
displayed on the particle surface, creating the so-called overcoat 
(Cruz et  al., 1996), which allows PVX particles to be used, for 
example, as optical probes for imaging in plant cells (Linnik et al., 
2013). The stability and functionality of these particles were also 
confirmed in mammalian cells and tissues (Shukla et al., 2014).
In this study, we created a production system for hybrid 
chimeric PVX particles displaying different polypeptides as CP 
fusions. For this, we used combinations of PVX and TMV expres-
sion vectors, each expressing different PVX CP fusions. The 
coinfection capacity of PVX and TMV vectors has been described 
earlier and is, for example, used for the production of recombinant 
antibodies (Giritch et  al., 2006), confirming the coexpression 
of different transgenes in the same cells. To prove the principle 
of the assembly of hybrid chimeric PVX virions, we chose the 
green fluorescent protein (GFP) and the red fluorescent protein 
mCherry, as well as a bimolecular fluorescence complementation 
(BiFC) system with split-mCherry as CP fusion proteins.
MaTerials anD MeThODs
Plasmid constructs
The expression constructs containing the GFP and mCherry CP 
fusions were assembled using PCR to add PacI and NotI restric-
tion sites. The PVX expression vectors pTCXI (GFP-2A-CP) and 
pTCXIIc (mCherry-2A-CP) were used as templates (Shukla et al., 
2014). Forward primers PacI-GFP (5′-AGT TAA TTA ATG AGT 
AAA GGA GAA G-3′) and PacI-mCherry (5′-AGT TAA TTA 
ATG GTG AGC AAG GGC G-3′) with reverse primer CP-NotI 
(5′-TTG CGG CCG CTT ATG GTG GTG GTA G-3′) were used. 
The resulting PCR products and the target TMV vector pJL36 
[kindly provided by Lindbo (2007)] were digested with PacI and 
NotI (NEB). The final constructs were prepared by joining the 
fragments with T4-DNA ligase (Promega) overnight at 16°C. The 
ligation products were introduced into Escherichia coli DH5α and 
colonies were selected on LB plates supplemented with 50 mg/ml 
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kanamycin overnight at 37°C. Plasmid DNA was isolated from 
overnight cultures and sequenced. The resulting plasmids were 
called pTMV-GFP-2A-CPPVX and pTMV-mCherry-2A-CPPVX. 
The split-mCherry sequence was constructed essentially as 
described by Fan et  al. (2008), with the mCherry split-site at 
residues 159/160. Either the C-terminal (NheI-C-mC: 5′-ACC 
AGC TAG CGC TAC CGG TCG CCA CCA TGG GCG CCC 
TGA AGG GCG AGA TC-3′ and mCherry-BspEI: -5′-TCC 
GGA CTT GTA CAG CTC GTC CAT-3′) or N-terminal (N-mC-
BspEI: 5′-CTT AAG AAG GTC AAA ATT TCT AGA TCC GGA 
GTC CTC GGG GTA CAT CCG CT-3′ and TGB-fw: 5′-AAG 
GGC CAT TGC CGA TCT CAA GC-3′) part of mCherry was 
amplified by PCR, adding the restriction sites NheI and BspEI 
for cloning in the PVX vector. After construction of the PVX vec-
tors with the split-mCherry components (pPVX-N-mC-2A-CP 
and pPVX-C-mC-2A-CP), the sequence with the CP fusion 
construct was amplified by PCR adding the restriction sites PacI 
(PacI-N-mC: 5′-AGT TAA TTA ATG GTG AGC AAG GGC G-3′ 
or PacI-C-mC: 5′-CGT GTT CTT GTC ATT AAT TAA TGG 
GCG CCC TGA AGG GCG AGA TC-3′) and NotI (CP-NotI) 
for cloning into the TMV vector, resulting in expression vectors 
pTMV-N-mC-2A-CPPVX and pTMV-C-mC-2A-CPPVX.
Plant inoculation and Maintenance
For inoculation with PVX vectors, 4-week-old Nicotiana 
benthamiana plants were dusted with Celite 545 (3–4 leaves per 
plant) and then rubbed with 10 μg plasmid DNA per leaf. PVX 
vectors were introduced into Agrobacterium tumefaciens strain 
GV3101:pMP90RK and TMV vectors were introduced into A. 
tumefaciens strain GV2260. The bacteria were cultivated at 26°C 
in YEB medium (0.5% beef extract, 0.1% yeast extract, 0.5% 
peptone, 0.5% sucrose, and 2  mM MgSO4) supplemented with 
100 mg/l carbenicillin, 50 mg/l rifampicin, and 25 mg/l kanamy-
cin. The cultures were pre-induced with 10 mM MES (pH 5.6), 
10 mM glucose, and 20 μM acetosyringone after 24 h of growth. 
After 48 h, the cultures were diluted to OD600nm = 0.5 for TMV vec-
tors and OD600nm = 1 for PVX vectors with 2× infiltration medium 
[100  g/l sucrose, 3.6  g/l glucose, 8.6  g/l Murashige and Skoog 
(MS) salts, pH = 5.6] supplemented with 200 μM acetosyringone 
and incubated for 30 min at room temperature. Four-week-old 
N. benthamiana plants were then inoculated by syringe without 
a needle and incubated at 26°C for 12 h in the dark at 20°C for 
12 h in a phytochamber with constant light (25,000–30,000 lux).
Protein isolation and analysis
Total soluble protein was isolated from harvested leaves by 
homogenizing leaf tissue in two volumes of phosphate-buffered 
saline (PBS). Insoluble debris was removed by centrifugation 
(13,000 rpm, 10 min, 4°C) and protein samples were resolved by 
SDS-PAGE (Laemmli, 1970) after mixing plant sap with 5× reduc-
ing buffer (62.5 mM Tris–HCl pH 6.8, 30% glycerol, 4% SDS, 10% 
2-mercaptoethanol, and 0.05% bromophenol blue). The samples 
were either visualized directly in the gel to confirm the presence 
of the fluorescent proteins or they were boiled for 5–10 min for 
western blotting. Samples were separated on 12% polyacrylamide-
SDS gels and then either stained with Coomassie Brilliant Blue or 
blotted onto a nitrocellulose membrane (HybondC, Amersham) 
for western blot analysis. The membranes were blocked for 1 h 
with 5% skimmed milk in PBS and incubated with a polyclonal 
antibody against PVX CP (DSMZ, Braunschweig, Germany), 
TMV CP (Bioreba, Switzerland), DsRed, or GFP (GeneTex, 
Irvine, CA, USA) for at least 2 h at room temperature. The DsRed 
antibody recognizes mCherry because the latter is a monomeric 
form directly derived from DsRed. A monoclonal alkaline phos-
phatase-conjugated goat anti-rabbit antibody (GARAP) was used 
as the secondary antibody (Dianova, Hamburg, Germany) and 
the signal was visualized with nitroblue tetrazolium chloride/5-
bromo-4-chloro-3-indolyphosphate p-toluidine salt (NBT/BCIP).
Detection of Fluorescence
The plants were monitored daily and analyzed for GFP fluores-
cence using a handheld UV lamp (7000 μW, Novodirect, Kehl/
Rhein, Germany) and for mCherry fluorescence with green light 
(KL2500 LCD, Schott AG, Mainz, Germany) and a red filter. 
Pictures were taken with a Nikon Coolpix 5400 camera (Nikon, 
Düsseldorf, Germany). For microscopic analysis, plant parts 
were analyzed with a Biorevo BZ-9000 fluorescence microscope 
(Keyence, Neu-Isenburg, Germany).
Particle Purification
Plant material was harvested 14–21 dpi depending on the infec-
tion status, and 50 g of plant material was used for virus purifica-
tion with a modified protocol from CIP (International Potato 
Center, Lima, Peru), as previously described (Uhde-Holzem 
et al., 2010). PEG precipitation was carried out as described in 
the original protocol, but the centrifugation on a sucrose cush-
ion was skipped because we lost too many particles during this 
step. Therefore, the centrifugation of the pooled fractions of the 
sucrose gradient continued for at least 3 h. The virus concentra-
tion was determined at OD260nm and the extinction coefficient of 
3.0 for TMV because the TMV concentration in the mixtures 
tended to be greater.
Transmission electron Microscopy
The particles were either directly adsorped to grids for transmis-
sion electron microscopy (TEM), or processed for immunosorb-
ent transmission electron microscopy (ISEM) as followed. For the 
adsorption grids, 20 μg of purified particles was incubated on 
Pioloform-coated 400-mesh nickel grids for 20 min. For ISEM, the 
grids were coated with the first antibody either α-PVX, α-DsRed 
or α-GFP antibodies diluted 1:10 in PBS for 20 min. Unbound 
antibodies were washed off with PBST [PBS supplemented with 
0.2% (w/v) Tween 20] and the grids were blocked with 0.5% (v/v) 
bovine serum albumin (BSA) in PBS for 15 min. Subsequently, 
the grids were incubated with 20 μg of the particle preparation for 
20 min, followed by washing with PBS. Captured PVX particles 
were analyzed for fluorescent proteins on the surface by immuno-
gold staining. Therefore, the preparations were incubated for 2 h 
with the α-PVX, α-mCherry, or α-GFP antibodies diluted 1:100 
in PBS. Primary antibodies were detected by overnight incuba-
tion with goat anti-rabbit secondary antibodies labeled with 
15-nm gold particles diluted 1:50 in PBS, recognizing the bound 
specific antibodies. Afterward, the grids were washed thoroughly 
with PBS and then with distilled water and counterstained with 
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1% (w/v) uranyl acetate (pH 4.3) before analysis with a Zeiss EM 
10 TEM (Oberkochen, Germany).
resUlTs
coexpression of PVX-gFP-2a-cP and 
TMV-mcherry-2a-cPPVX
We constructed TMV-based vectors expressing the PVX CP 
joined to fluorescent proteins mCherry or GFP via a FDMV 
2A peptide (Figure  1). We used the mCherry-2A-CPPVX and 
GFP-2A-CPPVX fusions from PVX vectors, which incorporate 
the mCherry/GFP-2A-CPPVX fusion along with the wt CPPVX into 
the particle, as previously reported (Shukla et  al., 2014). These 
CPPVX fusion sequences were cloned into the expression cassette 
of the TMV-based vector pJL36 (Lindbo, 2007). The resulting 
vectors (pTMV-mCherry-2A-CPPVX and pTMV-GFP-2A-CPPVX) 
express the PVX CP fusions under the control of an additional 
heterologous subgenomic promoter-like sequence. Viral vectors 
were inoculated into plants and coexpressed with a PVX vector 
expressing the corresponding other fluorescent PVX CP fusion 
protein.
Plants infected with the individual viral vectors showed 
systemic infection and overall strong GFP or mCherry expres-
sion in the infected leaves, as well as expression of the PVX and 
TMV CP (Figure 2; Figure S1 in Supplementary Material). The 
fluorescence intensity was lower with the TMV vectors than the 
PVX vectors. Coinfections with two vectors based on the same 
virus (e.g., PVX-GFP-2A-CP and PVX-mCherry-2A-CP) led to 
the spatial separation of the viruses as they spread through the 
host plant (Figures 3C,D), and in most cases, one vector became 
dominant. However, in coinfections with PVX and TMV vectors 
expressing different CPPVX fusions, we observed the coexpression 
of the different fluorescent proteins in the same parts of the plant 
(Figures 3A,B). Furthermore, the expression of the PVX-based 
fluorescent protein was enhanced in coinfections with TMV.
The coexpression of both fluorescent proteins in the same 
plant cells was confirmed by epifluorescence microscopy 
(Figure 4). Fluorescent proteins were also transiently expressed 
as a control by agroinfiltration, using the pTRA vector (Maclean 
et al., 2007). Plant cells coinfiltrated with both vectors showed 
simultaneous GFP and mCherry expression, which was con-
firmed by the yellow color in the overlay picture (Figures 4A–C). 
In plants coinfected with two PVX vectors expressing different 
CP fusions (Figures 4D–F) or TMV vectors (data not shown), 
no coexpression was observed. Vectors based on the same virus 
backbones excluded each other, and sharp boundaries for GFP 
or mCherry expression were noted. In contrast, a combination 
of TMV- and PVX-based vectors coinfected the same cells, both 
expressing a PVX CP fusion protein (Figures 4G–I).
SDS-PAGE analyses allowed direct visualization of the fluo-
rescent proteins in gels, and the confirmation of CP expression in 
western blots (Figure S1 in Supplementary Material and data not 
shown). These experiments confirmed the coexpression of differ-
ent CPPVX fusions in the same leaves and the same cells following 
coinfection with PVX and TMV vectors, but did not reveal the 
PVX particle composition.
Particle analysis Presenting Full-size 
Fluorescent Proteins
Virus particles were purified from the coinfected plant material 
and the particle structure was analyzed to find out whether both 
fluorescent proteins can be incorporated into the same particles. 
Following purification, the particle preparations were analyzed by 
western blot and TEM, using specific antibodies against mCherry 
FigUre 1 | schematic overview of the used plant viral vectors with fluorescent proteins (a) or split-mcherry (B). (a) PVX-based vectors with fluorescent 
protein fusions with the help of the 2A sequence of the FDMV are used, as for example the GFP-2A-fusion is shown. The PVX CP fusion was introduced into 
TMV-based expression vectors, either with mCherry or with GFP. (B) As second option, split-mCherry was used instead of fluorescent proteins. Therefore, either the 
N- or C-terminal part of mCherry was cloned into the viral vectors. RdRp, RNA-dependent RNA polymerase; p25, p12, and p8, triple gene block proteins; CP, coat 
protein; 126 and 183 kDa, replicase complex of TMV; MP, movement protein; m7G, methyl guanidine cap; poly(A), polyadenylated tail; tRNA-like, tRNA-like structure 
of TMV.
FigUre 2 | Nicotiana benthamiana plants at 12 dpi expressing 2a-cPPVX fusions with fluorescent proteins in PVX or TMV vectors. The plants are 
shown under normal light and with specific excitation of the fluorescent proteins. For GFP, the plants are shown under UV light, and for mCherry, they are shown 
under green light with a red filter.
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and GFP. TMV and PVX particles co-accumulated during puri-
fication because the process does not separate them. SDS-PAGE 
revealed the presence of excess TMV particles compared to PVX, 
with an approximate ratio of 3:1 (Figure S1 in Supplementary 
Material; Figure 5). Consequently, 1 μg of the particle prepara-
tion was used for TMV analysis, and 3 μg was used for PVX, GFP, 
and mCherry analysis.
Western blots confirmed the presence of CPTMV (17.5 kDa) and 
CPPVX (25 kDa) in the preparation. GFP (25 kDa) was detected 
in all pooled fractions, but only pooled fraction 2 contained the 
GFP-CPPVX fusion product (Figure 5, indicated by the arrowhead, 
54  kDa). Small amounts of the mCherry fusion product were 
also detected in this fraction using the DsRed antibody (54 kDa). 
This confirmed the presence of PVX particles with either GFP or 
mCherry overcoat fusions (Figure 5).
To determine whether both fluorescent protein overcoat struc-
tures are found on the same particles, the particles were either 
directly absorbed to grids for TEM analysis or captured with 
specific antibodies recognizing the fluorescent proteins or PVX. 
Control PVX and TMV particles were not captured or labeled 
with the GFP-specific or DsRed-specific antibodies, confirming 
the specific binding of these antibodies to the fluorescent proteins 
(Figure S2 in Supplementary Material). The TMV particles were 
generally not captured or labeled by the PVX-specific antibody, 
but a few undecorated particles were found on all grids with TMV. 
Cross-reactivity of the antibodies against the other fluorescent 
protein was excluded by purifying either the PVX-GFP-2A-CP 
or PVX-mCherry-2A-CP particles. Particles displaying a GFP 
overcoat were only captured and decorated by α-GFP, and 
mCherry overcoat structures were only labeled and captured by 
α-DsRed (Figure S2 in Supplementary Material). In the virus 
preparation from plants coinfected with PVX-GFP-2A-CP and 
TMV-mCherry-2A-CPPVX, a mixture of TMV and PVX particles 
was observed, because the PVX purification process cannot sepa-
rate these viruses. The TMV particles are shorter (~300 nm) and 
have a rigid structure, whereas the PVX particles are >500 nm in 
length and have a flexible structure, thus allowing the particles to 
be visually distinguished on the grids. Particles from the coex-
pression were captured and labeled with both the GFP-specific 
and DsRed-specific antibodies.
The presence of both fluorescent proteins on the surface of 
PVX particles could be verified by capturing either with the 
DsRed antibody and labeling with α-GFP or vice  versa. PVX 
particles could be captured from the preparations using either 
of the antibodies, confirming that at least one fluorescent protein 
can be found on the surface. Furthermore, some of these captured 
particles were decorated with the antibody against the second flu-
orescent protein, indicating that both fluorescent protein fusions 
can indeed assemble into one intact PVX particle (Figure 6).
coexpression of split-mcherry-cPPVX 
Fusions
We next used the BiFC system with split-mCherry to confirm 
the assembly of chimeric particles after coexpression of the 
different PVX CPs. Instead of mCherry and GFP, we used the N- 
and C-terminal portions of split-mCherry (N-mC or C-mC) as 
2A-CPPVX fusions, and expressed them using either a PVX vector 
or a TMV vector (Figure 1B). We combined the vectors pPVX-N-
mC-2A-CP and pTMV-C-mC-2A-CPPVX or pPVX-C-mC-2A-CP 
and pTMV-N-mC-2A-CPPVX for coinfection studies. With this 
system, red fluorescence would only be generated if both parts of 
the split-mCherry CP fusions are expressed in the same cells and 
interact with each other.
FigUre 3 | Nicotiana benthamiana plants coinfected with PVX and TMV vectors expressing cP fusions of PVX at 12 dpi displayed as whole plant. 
Plants were coinfected with (a) PVX-GFP-2A-CP and TMV-mCherry-2A-CPPVX, (B) PVX-mCherry-2A-CP and TMV-GFP-2A-CPPVX, (c) PVX-GFP-2A-CP and 
PVX-mCherry-2A-CP, and (D) TMV-mCherry-2A-CPPVX and TMV-GFP-2A-CPPVX. The plants are shown under normal light and with excitation of the fluorescent 
proteins (UV light for GFP and green light with a red filter for mCherry).
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Plants were infected with each construct alone and pairwise 
combinations. No fluorescence was detected in single infections, 
or coinfections with two PVX- or TMV-based vectors express-
ing the different split-mCherry parts (Figures  7A–D and data 
not shown). Expression of the split-mCherry-2A-CPPVX was 
confirmed by immunocapture RT-PCR and western blot analysis 
(Figures S3 and S5 in Supplementary Material). In plants coin-
fected with a combination of PVX and TMV vectors expressing 
different parts of the split-mCherry, only weak fluorescence was 
observed in infected leaves and was confirmed by fluorescence 
microscopy in the cells (Figures 7E–F). In all infections, the com-
bination of the C-terminal part of the split-mCherry expressed 
from the PVX vector and the N-terminal part expressed from 
the TMV vector gave more intense red fluorescence than the 
reciprocal arrangement.
The split-mCherry data confirmed the coexpression of the two 
different viral vectors in a single cell, but we could not rule out 
the possibility that interactions might occur free in the cytosol, 
e.g., as CP dimers rather than in the context of an assembled 
particle. Therefore, particles were purified from infections with 
PVX-N-mC-2A-CP, PVX-C-mC-2A-CP and coinfections with 
a TMV vector expressing the other portion of split-mCherry, 
respectively. During purification via sucrose gradients, we 
obtained fractions (16–20) of the purified particles showing 
red fluorescence (Figure S4 in Supplementary Material). This 
indicated that the split-mCherry components may be able to 
form a functional fluorescent protein on the particle surface. 
We used TEM to determine whether the DsRed antibody could 
detect the split parts of mCherry even though the antibody could 
not detect the split-mCherry parts in western blot (Figure S5 in 
Supplementary Material). The adsorption grids showed again a 
mixture of TMV and PVX particles with an approximate ratio 
of 3:1 (Figures 8B,C). PVX particles were either captured with 
the DsRed antibody and labeled after capture with the PVX 
antibody or vice  versa. We were unable to capture particles of 
the PVX control and particles displaying only one split-mCherry 
component by the DsRed antibody or label particles after capture 
with α-PVX when using the DsRed antibody. This confirmed 
that the DsRed antibody can only detect the complete mCherry 
protein and not the individual split components (Figure  8; 
Figure S5 in Supplementary Material). However, we were able 
to capture PVX particles from preparations derived from virus 
coinfections using the same α-DsRed antibody in both coexpres-
sions of the split mCherry CP fusions. Furthermore, we were 
FigUre 4 | Plant cells were analyzed by fluorescence microscopy with a 10× magnification. (a–c) Coexpression of GFP and mCherry with pTRAc vectors 
(positive control), (D–F) coinfection with PVX-GFP-2A-CP and PVX-mCherry-CP, (g–i) coinfection of PVX-mCherry-2A-CP and TMV-GFP-2A-CPPVX; (a,D,g) cells 
shown with excitation of mCherry (Texas red filter), (B,e,h) cells shown with GFP excitation, (c,F,i) overlay of the pictures for the shown coexpression.
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able to label the particles with the DsRed-specific antibody after 
capturing the particles with the PVX antibody from the PVX/
TMV mixture (Figures 8H,I). We observed a better labeling with 
the α-DsRed antibody in particles derived from the coinfection 
if the C-terminal split-mCherry part is expressed by PVX. The 
detection of functional mCherry on the particle surface proves 
the assembly of hybrid chimeric PVX particles.
DiscUssiOn
We have developed a novel production system for hybrid chimeric 
virus particles with at least two different polypeptides presented 
on the surface. With help of the FDMV 2A sequence, we were 
able to display rather large proteins on the recombinant particle 
(the fluorescent proteins GFP and mCherry), and also displayed 
the two split-mCherry portions, which interacted on the particle 
surface.
coexpression of Two cPPVX Fusion 
Proteins Using PVX- and TMV-Based 
Vectors
We could show that a full-size PVX expression vector accepts the 
coexpression of additional PVX CP fusion protein delivered by a 
different viral expression vector. We found that PVX expression is 
enhanced in the presence of the TMV vector, resulting in brighter 
fluorescence for the PVX multiplication expressed fluorescent 
protein (Figure 3, mCherry fluorescence in Figure 3B compared 
to Figure 3C). The enhancement of PVX in a TMV-PVX coin-
fection is well known (Goodman and Ross, 1974) and was also 
observed in our system.
The fluorescence intensity of both proteins delivered by the 
TMV vectors was always lower than those delivered by the PVX 
vectors, although TMV accumulated to higher titers. This can 
possibly be explained by the distance of the fluorescent protein 
sequence relative to the 3′-end of the TMV genome (Culver et al., 
1993). The distance between the genes for GFP or mCherry and 
the 3′-end is increased by the additional CPPVX sequence, which 
limits the expression of the fluorescent protein. If the same 
fluorescent protein is expressed alone by the TMV vector, much 
more intense fluorescence and expression is observed (Lindbo, 
2007). The influence of the relative distance of the gene of inter-
est from the 3′-end of viral genomes could be explained by the 
impact of non-sense-mediated decay (NMD). In a recent study, it 
could be shown that long 3′-untranslated regions in subgenomic 
RNAs resulting from gene insertions into PVX vectors trigger 
the intrinsic restriction pathway in plants for plus-sense RNA 
viruses, namely NMD (Garcia et  al., 2014). We speculate that 
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this phenomenon might also explain why the genes located at the 
veriest 3′-end of viral genomes with 3′-coterminal subgenomic 
RNAs is in most cases expressed strongest. Thus, alternative 
FigUre 5 | analysis of purified PVX and TMV particles with gFP-2a-cPPVX and mcherry-2a-cPPVX fusions. The particles were purified from a PVX-GFP-
2A-CP plus TMV-mCherry-2A-CPPVX coinfection and the preparation was analyzed by western blot to detect CPPVX (α-PVX), CPTMV (α-TMV), GFP (α-GFP), and 
mCherry (α-DsRed) using GARAP as the secondary antibody. M: P7711S protein ladder (NEB), 1–3: different pooled fractions of the preparation, T: purified TMV 
particles (0.5 μg), P: purified PVX particles (0.5 μg), G: GFP control (plant sap expressing GFP from a pTRAc vector), mC: mCherry control (plant sap expressing 
mCherry from a pTRAc vector). For PVX, GFP, and mCherry, 3 μg of the particle mixture was separated by SDS-PAGE. Only 1 μg was used for TMV analysis. The 
pooled fraction 2 was analyzed in TEM (Figure 6). The same amount of purified particles (10 μg) was used for the grids.
FigUre 6 | TeM analysis of chimeric PVX particles displaying gFP and mcherry overcoat structures. After coinfection with PVX-GFP-2A-CP and 
TMV-mCherry-2A-CPPVX, particles were captured with α-DsRed and decorated with α-GFP (a,B), or captured with α-GFP and decorated with α-DsRed (c,D). 
Bar = 500 nm.
expression strategies, e.g., 2A ribosomal skip sequences (Cruz 
et al., 1996; Gopinath et al., 2000), internal ribosome entry sites 
(Toth et al., 2001), or stop codon suppression (Hamamoto et al., 
FigUre 7 | Nicotiana benthamiana cells analyzed for red fluorescence resulting from interactions of split-mcherry at 14 dpi. Cells are shown in 10× 
magnification and specific excitation for mCherry was applied with a Texas Red filter (B,D,F,h). The upper pictures show the overlay of transmitted light and the 
specific fluorescence excitation (a,c,e,g). (a,B) N. benthamiana non-infected, (c,D) plant infected with PVX-C-mC-2A-CP and PVX-N-mC-2A-CP, (e,F) coinfection 
of PVX-N-mC-2A-CP and TMV-C-mC-2A-CPPVX, and (g,h) coinfection of PVX-C-mC-2A-CP and TMV-N-mC-2A-CPPVX.
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1993) could be advantageous. In PVX vectors, it can be observed 
that expression via a 2A-sequence fusion (this study and Cruz 
et al., 1996; Shukla et al., 2014) yield better results compared to 
an additional subgenomic promoter-like sequence (Baulcombe 
et al., 1995; Dickmeis et al., 2014).
Because coexpression of PVX CPs with different viral vec-
tors was possible in the same cells, it was interesting to find out 
whether hybrid chimeric particles would be generated as well. 
We have identified PVX particles with different foreign PVX CP 
fusions assembled into the virion structure (Figure 6; Figure S2 
in Supplementary Material), thus confirming the construction of 
chimeric PVX particles with a hybrid GFP and mCherry overcoat 
structure. This shows that PVX CP delivered by TMV can interact 
with PVX genomic RNA, giving initial hints that virion formation 
is not strictly coupled to CP production.
Bimolecular Fluorescence 
complementation
To analyze our expression system in more detail, we used the 
mCherry BiFC components (Fan et al., 2008) as fusion proteins 
in our PVX overcoat system. The BiFC system allows the analy-
sis of protein interactions in vivo by fusing different parts of a 
fluorescent protein to the target proteins (Kodama and Wada, 
2009). The fluorescent proteins are split and fluorescence can 
only be restored through the interaction of the target proteins. 
Plant viral CPs known to assemble without RNA were transiently 
expressed by A. tumefaciens for the evaluation of a monomeric 
red fluorescent protein (mRFP)-based BiFC system, because of 
their definite interaction capacity (Zilian and Maiss, 2011). The 
CPs of TMV, Plum pox virus (PPV), and capsicum chlorosis virus 
(CaCV) were shown to interact in the plant cells with itself after 
transient expression and by direct fusions of the split-mRFP por-
tions to the CPs or a 7 amino acid linker sequence in between; 
however, full-sized particle formation has not been investigated. 
We used split-mCherry to confirm the coexpression of two viral 
vectors in the same cells. Restoration of the red fluorescence 
showed the coexpression of the two different PVX CP fusion pro-
teins (Figure 7). Still, mCherry fluorescence does not necessarily 
confirm the interaction of the split-mCherry components during 
particle assembly, which may be explained by low potential inter-
action of free split-mCherry components (Morell et al., 2007) by 
the formation of CP dimers and oligomers.
We then analyzed the purified particles for the presence of 
mCherry restored from the split components. PVX particles dis-
playing only one split-mCherry component were not labeled by 
the α-DsRed antibody, whereas some particles derived from the 
coexpression with the TMV/PVX combination were either cap-
tured or labeled by the DsRed antibody (Figure 8). Interestingly, 
we obtained a better labeling with the α-DsRed antibody if 
the C-terminal split-mCherry is expressed by the PVX vector, 
indicating a higher amount of particles with restored mCherry. 
The 9-kDa C-terminal split-mCherry is the smaller part of the 
mCherry protein (27 kDa). Thus, it seems to be more favorable 
for the construction of hybrid chimeric PVX particles to express 
the smaller peptide in the context of the PVX vector.
We have developed a plant expression system for the produc-
tion of novel hybrid chimeric PVX particles, presenting two 
different overcoats on the surface. The PVX virion is a suitable 
epitope presentation system with 1270 CP subunits comprising 
each particle, thus a well-defined number of epitopes can be pre-
sented in high density to the immune system. PVX has been used 
successfully to present different epitopes and trigger an efficient 
immune response in animal models (Marusic et al., 2001; Lico 
et  al., 2006). However, only single tandem repeats of epitopes 
have been presented on PVX as CP fusions (Uhde-Holzem et al., 
2010). With our system, at least two different epitopes or even 
more in combinations with tandem repeats can be presented 
on the particle surface. We proved the system with fluorescent 
FigUre 8 | analysis of purified PVX particles in TeM studies with split-mcherry. For TEM analysis of the particles, the preparations were either directly 
adsorbed to the grids (a–c) or captured with a DsRed-specific antibody and labeled with a PVX-specific antibody with GAR15nm (D–F) or captured with a 
PVX-specific antibody and labeled with a DsRed-specific antibody with GAR15nm (g–i). PVX purification was used as control (a,D,g), the purification of the 
coinfection of PVX-C-mC-2A-CP and TMV-N-mC-2A-CPPVX (B,e,h), and the coinfection of PVX-N-mC-2A-CP and TMV-C-mC-2A-CPPVX (c,F,i) are displayed. 
Bars = 500 nm.
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proteins, to directly visualize the expression of a second PVX CP 
in planta by another viral vector. We utilized the 2A sequence to 
obtain a hybrid overcoat structure on the PVX particles with the 
fluorescent proteins because these large proteins would impair 
particle assembly as a direct fusion. For epitope presentation, 
the epicoat structure with a particle completely decorated with 
epitopes would be more favorable.
During particle purification, TMV particles derived from 
the expression system were isolated as well (i.e., Figures 5 and 
6). Thus, with a supplementary presentation of epitopes on 
the TMV particle surface, an even stronger vaccine candidate 
might be created. In all our particle purifications, we observed a 
ratio of TMV and PVX particles of ~3:1. The system, therefore, 
offers an additional possibility for tuning epitope presentation. 
Depending on the target pathogens, epitopes that induce a 
comparably low immune response can be presented on the 
TMV particles (which generate the largest number of puri-
fied particles in the mixture) and the comparably stronger 
epitopes can be displayed on PVX particles. The advantage of 
the coexpression is an easy purification of both rod-shaped 
particles in one procedure. Thus, our system provides a novel 
alternative expression platform for multicomponent/epitope 
immunization.
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